Literature DB >> 30076569

Multi-level Influences on Breast Cancer Screening in Primary Care.

Tracy Onega1,2,3, Tor D Tosteson1,2,3, Julie Weiss1, Jennifer S Haas4,5,6, Martha Goodrich7,8, Roberta DiFlorio9, Charles Brackett10, Cheryl Clark4, Kimberly Harris4, Anna N A Tosteson2,3.   

Abstract

BACKGROUND: Use of breast cancer screening is influenced by factors associated with patients, primary care providers, practices, and health systems.
OBJECTIVE: We examined the relative effects of these nested levels on four breast cancer screening metrics.
DESIGN: A web-based survey was completed at 15 primary care practices within two health systems representing 306 primary care providers (PCPs) serving 46,944 women with a primary care visit between 1/2011-9/2014. Analyses occurred between 1/2017 and 5/2017. MAIN MEASURES: Across four nested levels (patient, PCP, primary care practice, and health system), frequency distributions and adjusted rates of primary care practice characteristics and survey results for four breast screening metrics (percent screened overall, and percent screened age 40-49, 50-74, and 75+) were reported. We used hierarchical multi-level mixed and random effects analysis to assess the relative influences of PCP, primary care practice, and health system on the breast screening metrics. KEY
RESULTS: Overall, the proportion of women undergoing breast cancer screening was 73.1% (73.4% for ages 40-49, 76.5% for 50-74, and 51.1% for 75+). Patient ethnicity and number of primary care visits were strongly associated with screening rates. After adjusting for woman-level factors, 24% of the overall variation among PCPs was attributable to the primary care practice level, 35% to the health system level, and 41% to the residual variation among PCPs within practice. No specific provider-level characteristics were found to be statistically significant determinants of screening rates.
CONCLUSIONS: After accounting for woman-level characteristics, the remaining variation in breast cancer screening was largely due to provider and health system variation.

Entities:  

Keywords:  breast cancer screening; primary care practice breast screening

Mesh:

Year:  2018        PMID: 30076569      PMCID: PMC6153219          DOI: 10.1007/s11606-018-4560-1

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  17 in total

1.  Alignment of breast cancer screening guidelines, accountability metrics, and practice patterns.

Authors:  Tracy Onega; Jennifer S Haas; Asaf Bitton; Charles Brackett; Julie Weiss; Martha Goodrich; Kimberly Harris; Steve Pyle; Anna N A Tosteson
Journal:  Am J Manag Care       Date:  2017-01       Impact factor: 2.229

2.  Medical home transformation and breast cancer screening.

Authors:  Amy W Baughman; Phyllis Brawarsky; Tracy Onega; Tor D Tosteson; Qianfei Wang; Anna N A Tosteson; Jennifer S Haas
Journal:  Am J Manag Care       Date:  2016-11-01       Impact factor: 2.229

3.  Systems strategies to support cancer screening in U.S. primary care practice.

Authors:  K Robin Yabroff; Jane Zapka; Carrie N Klabunde; Gigi Yuan; Dennis W Buckman; David Haggstrom; Steven B Clauser; Jacqueline Miller; Stephen H Taplin
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-10-05       Impact factor: 4.254

4.  Effects of adenosine on sympathetic vasoconstriction in dog gracilis muscle.

Authors:  R E Klabunde
Journal:  J Pharmacol Exp Ther       Date:  1987-01       Impact factor: 4.030

5.  Unifying screening processes within the PROSPR consortium: a conceptual model for breast, cervical, and colorectal cancer screening.

Authors:  Elisabeth F Beaber; Jane J Kim; Marilyn M Schapira; Anna N A Tosteson; Ann G Zauber; Ann M Geiger; Aruna Kamineni; Donald L Weaver; Jasmin A Tiro
Journal:  J Natl Cancer Inst       Date:  2015-05-07       Impact factor: 13.506

6.  Cancer screening practices among racially and ethnically diverse breast cancer survivors: results from the 2001 and 2003 California health interview survey.

Authors:  Erica S Breslau; Diana D Jeffery; William W Davis; Richard P Moser; Timothy S McNeel; Sarah Hawley
Journal:  J Cancer Surviv       Date:  2009-11-02       Impact factor: 4.442

7.  Processes of care in cervical and breast cancer screening and follow-up--the importance of communication.

Authors:  Jane G Zapka; Elaine Puleo; Stephen H Taplin; Karin Valentine Goins; Marianne Ulcickas Yood; Judy Mouchawar; Carol Somkin; M Michele Manos
Journal:  Prev Med       Date:  2004-07       Impact factor: 4.018

8.  Factors influencing adherence to guidelines for screening mammography among women aged 40 years and older.

Authors:  Saleh M M Rahman; Mark B Dignan; Brent J Shelton
Journal:  Ethn Dis       Date:  2003       Impact factor: 1.847

9.  Screening Mammography Use Among Older Women Before and After the 2009 U.S. Preventive Services Task Force Recommendations.

Authors:  Chiang-Hua Chang; Julie P W Bynum; Tracy Onega; Carrie H Colla; Jon D Lurie; Anna N A Tosteson
Journal:  J Womens Health (Larchmt)       Date:  2016-07-18       Impact factor: 2.681

10.  Mammography facility characteristics associated with interpretive accuracy of screening mammography.

Authors:  Stephen Taplin; Linn Abraham; William E Barlow; Joshua J Fenton; Eric A Berns; Patricia A Carney; Gary R Cutter; Edward A Sickles; D'Orsi Carl; Joann G Elmore
Journal:  J Natl Cancer Inst       Date:  2008-06-10       Impact factor: 13.506

View more
  2 in total

1.  Variation in the receipt of human papilloma virus co-testing for cervical screening: Individual, provider, facility and healthcare system characteristics.

Authors:  Jennifer S Haas; David Cheng; Liyang Yu; Steven J Atlas; Cheryl Clark; Sarah Feldman; Michelle I Silver; Aruna Kamineni; Jessica Chubak; Gaia Pocobelli; Jasmin A Tiro; Sarah C Kobrin
Journal:  Prev Med       Date:  2021-11-08       Impact factor: 4.018

2.  Examining Breast Cancer Screening Behavior Among Southern Black Women After the 2009 US Preventive Services Task Force Mammography Guideline Revisions.

Authors:  Deeonna E Farr; Heather M Brandt; Swann Arp Adams; Venice E Haynes; Andrea S Gibson; Dawnyéa D Jackson; Kimberly C Rawlinson; John R Ureda; James R Hébert
Journal:  J Community Health       Date:  2020-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.